sci-pharm
Powered by world-class molecular medicine expertise.
aboutSciphram Trading FZCO
Sciphram Trading FZCO in UAE was established in 2021 with
the vision to elevate the options for precision medicine with
the highest quality services in the molecular medicine sector,
offering comprehensive tumor profiling for targeted therapies
Scipharm was inspired and guided for this mission by creating
a partnership with one of the best 17 laboratories word wide in
molecular medicine quality assurance Genekor.
Genekor is developing highly sensitive and specific molecular
assays that are applicable in everyday clinical practice. With
our partners and our experienced personnel in the medical
field, we share the same goals to provide and assist
physicians in applying cutting edge technologies for
individualized medicine at affordable prices
Sci-Pharm
/ Transforming Cancer Care with Advanced Molecular Testing
/ Transforming Cancer Care with Advanced Molecular Testing
Our Lab’s clinical expertise focuses on
Response to Targeted Therapy
Pharmacogenetics
Determination of Hereditary Cancer, cardiovascular Diseases
and Neurological Disorders
New Unique Technological Platforms (Complit DX colon ,lung,breast /Heredigene DX /Prime DX /CordixDX/CerebrumDX, HerediGENETM, PrIMeTM, Cordis DXTM, Cerebrum DX TM, PCA3TM)
Watch video
Our Partnering Laboratory is certified internationally recognized and published scientists and doctors who are able to provide analysis and recommendations to physicians and their patients. Therefore Scipharm is in position to carry out all existing molecular biology assays and we offer to the treating physicians of various specialties tools to individualize their patients' treatment needs.
At scipharm, we are devoted at offering services of the highest quality, by constantly monitoring the scientific developments in the health sector Scipharm is actively establishing its regional presence with an ultimate goal to extend its collaborations in more countries.
Our partners strategic goal is the constant incorporation of new technology platforms and assays in order to always provide the most up-to-date, reliable and cutting edge tools to the treating physicians

